Breaking News Instant updates and real-time market news.

COST

Costco

$148.70

-1.45 (-0.97%)

07:45
10/18/16
10/18
07:45
10/18/16
07:45

Costco initiated at Wells Fargo

As noted earlier, Wells Fargo analyst Zachary Fadem initiated Costco with a $150-$155 price target and a Market Perform rating. Fadem thinks that the stock's long-term outlook is positive, but he advises waiting for a better entry point on the shares, all else being equal.

  • 18

    Oct

COST Costco
$148.70

-1.45 (-0.97%)

09/23/16
LEHM
09/23/16
INITIATION
Target $158
LEHM
Equal Weight
Costco assumed with an Equal Weight at Barclays
Barclays analyst Karen Short assumed coverage of Costco with an Equal Weight rating and $158 price target. The rating is unchanged from the firm's prior coverage and the price target is lowered from $180.
09/23/16
BARD
09/23/16
NO CHANGE
Target $175
BARD
Outperform
Costco weakness a buying opportunity, says Baird
Baird analyst Peter Benedict recommends buying Costco (COST) on its pullback as he believes the shares offer a compelling value proposition. The analyst also sees Costco as having a loyal membership model that remains a positive in today's challenging retail world. Benedict sees better traffic/sales later this year as comps ease and members recognize the benefits of the new co-branded Visa (V) card. He reiterated his Outperform rating and $175 price target on Costco shares.
10/03/16
BARD
10/03/16
NO CHANGE
Target $175
BARD
Outperform
Costco could see sluggish September comps, says Baird
Baird analyst Peter Benedict previewed September sales for Costco (COST). He believes comps could be sluggish as they are going against difficult comparisons. Looking ahead, however, he sees better traffic and sales as comparisons start to ease and members increasingly recognize the benefits of the new co-branded Visa (V) card. Benedict reiterated his Outperform rating and $175 price target on Costco shares.
10/18/16
WELS
10/18/16
INITIATION
WELS
Market Perform
Costco initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Zachary Fadem started Costco Wholesale with a Market Perform rating and $150-$155 price target range.

TODAY'S FREE FLY STORIES

QTS

QTS Realty Trust

$52.47

0.82 (1.59%)

05:50
01/17/18
01/17
05:50
01/17/18
05:50
Downgrade
QTS Realty Trust rating change  »

QTS Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LQ

La Quinta

$18.44

-0.03 (-0.16%)

05:50
01/17/18
01/17
05:50
01/17/18
05:50
Upgrade
La Quinta rating change  »

La Quinta upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASND

Ascendis Pharma

$47.60

1.02 (2.19%)

05:50
01/17/18
01/17
05:50
01/17/18
05:50
Recommendations
Ascendis Pharma analyst commentary  »

Ascendis Pharma price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLX

Shell Midstream

$30.74

0.21 (0.69%)

05:50
01/17/18
01/17
05:50
01/17/18
05:50
Downgrade
Shell Midstream rating change  »

Shell Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

ENR

Energizer

$59.11

7.49 (14.51%)

05:47
01/17/18
01/17
05:47
01/17/18
05:47
Downgrade
Energizer rating change  »

Energizer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 31

    Jan

ABB

ABB

$28.07

-0.02 (-0.07%)

05:46
01/17/18
01/17
05:46
01/17/18
05:46
Upgrade
ABB rating change  »

ABB upgraded to Hold from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

CELG

Celgene

$104.82

-1.18 (-1.11%)

, JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

05:45
01/17/18
01/17
05:45
01/17/18
05:45
Recommendations
Celgene, Juno Therapeutics analyst commentary  »

Jefferies believes $8B…

CELG

Celgene

$104.82

-1.18 (-1.11%)

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

DF

Dean Foods

$11.28

0.01 (0.09%)

05:45
01/17/18
01/17
05:45
01/17/18
05:45
Upgrade
Dean Foods rating change  »

Dean Foods upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$176.19

-0.9 (-0.51%)

05:44
01/17/18
01/17
05:44
01/17/18
05:44
Downgrade
Apple rating change  »

Apple downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

RGC

Regal Entertainment

$22.90

-0.07 (-0.30%)

05:43
01/17/18
01/17
05:43
01/17/18
05:43
Downgrade
Regal Entertainment rating change  »

Regal Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PII

Polaris Industries

$127.90

-2.13 (-1.64%)

05:43
01/17/18
01/17
05:43
01/17/18
05:43
Upgrade
Polaris Industries rating change  »

Polaris Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

DISH

Dish

$47.99

-1.49 (-3.01%)

05:42
01/17/18
01/17
05:42
01/17/18
05:42
Downgrade
Dish rating change  »

Dish downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

LBTYA

Liberty Global

$36.56

-0.31 (-0.84%)

05:42
01/17/18
01/17
05:42
01/17/18
05:42
Upgrade
Liberty Global rating change  »

Liberty Global upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IR

Ingersoll-Rand

$90.26

-0.84 (-0.92%)

, MIELY

Mitsubishi Electric

$36.44

0.035 (0.10%)

05:42
01/17/18
01/17
05:42
01/17/18
05:42
Hot Stocks
Ingersoll-Rand, Mitsubishi Electric establish JV for ductless and VRF systems »

Ingersoll-Rand (IR) and…

IR

Ingersoll-Rand

$90.26

-0.84 (-0.92%)

MIELY

Mitsubishi Electric

$36.44

0.035 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

EGHT

8x8, Inc.

$15.30

0.05 (0.33%)

05:42
01/17/18
01/17
05:42
01/17/18
05:42
Upgrade
8x8, Inc. rating change  »

8x8, Inc. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 25

    Jan

NVS

Novartis

$86.73

0.08 (0.09%)

05:38
01/17/18
01/17
05:38
01/17/18
05:38
Hot Stocks
Novartis granted FDA priority review for Kymriah »

Novartis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 08

    Feb

  • 16

    Feb

  • 23

    Apr

  • 17

    May

SKX

Skechers

$37.91

-0.64 (-1.66%)

05:38
01/17/18
01/17
05:38
01/17/18
05:38
Recommendations
Skechers analyst commentary  »

Skechers price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$100.69

-0.18 (-0.18%)

05:36
01/17/18
01/17
05:36
01/17/18
05:36
Hot Stocks
Walmart launches opioid disposal solution »

In an effort to help curb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

BLL

Ball Corp.

$38.39

0.49 (1.29%)

05:35
01/17/18
01/17
05:35
01/17/18
05:35
Upgrade
Ball Corp. rating change  »

Ball Corp. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

PBYI

Puma Biotechnology

$90.85

-8.4 (-8.46%)

05:34
01/17/18
01/17
05:34
01/17/18
05:34
Recommendations
Puma Biotechnology analyst commentary  »

Puma Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADTN

Adtran

$19.50

-0.2 (-1.02%)

05:30
01/17/18
01/17
05:30
01/17/18
05:30
Earnings
Adtran reports Q4 adj. EPS 5c, consensus (4c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

PSTG

Pure Storage

$16.16

-0.31 (-1.88%)

05:27
01/17/18
01/17
05:27
01/17/18
05:27
Upgrade
Pure Storage rating change  »

Pure Storage upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

PSDO

Presidio

$17.74

-0.96 (-5.13%)

05:25
01/17/18
01/17
05:25
01/17/18
05:25
Downgrade
Presidio rating change  »

Presidio downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNPR

Juniper

$28.61

-0.28 (-0.97%)

05:24
01/17/18
01/17
05:24
01/17/18
05:24
Downgrade
Juniper rating change  »

Juniper downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

IDTI

Integrated Device

$31.75

-0.54 (-1.67%)

, MRVL

Marvell

$23.58

-0.26 (-1.09%)

05:22
01/17/18
01/17
05:22
01/17/18
05:22
Upgrade
Integrated Device, Marvell rating change  »

Integrated Device…

IDTI

Integrated Device

$31.75

-0.54 (-1.67%)

MRVL

Marvell

$23.58

-0.26 (-1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.